Current management of acute myocardial infarction: Experience from the Korea Acute Myocardial Infarction Registry

Journal of Cardiology

Volumn 56, Issue 1, 2010, Pages 1-7

  Sim, Doo Sun ^a   Jeong, Myung Ho ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Acute myocardial infarction; Non ST elevation myocardial infarction; ST elevation myocardial infarction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTITHROMBOCYTIC AGENT; BRAIN NATRIURETIC PEPTIDE; CILOSTAZOL; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PACLITAXEL; RAPAMYCIN; TROPONIN; ZOTAROLIMUS;

ACUTE HEART INFARCTION; CEREBROVASCULAR DISEASE; CIRCADIAN RHYTHM; COMMUNITY HOSPITAL; COMORBIDITY; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE REGISTRY; DRUG ELIMINATION; FIBRINOLYTIC THERAPY; HEART DISEASE; HEART FAILURE; HEART MUSCLE REPERFUSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; KOREA; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBESITY; OUTPATIENT CARE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SEASONAL VARIATION; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TEACHING HOSPITAL; TREATMENT OUTCOME;

AGED; HUMANS; KOREA; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS;

EID: 77955554031     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2010.04.002     Document Type: Review

References (65)

1. Sim D.S., Kim J.H., Jeong M.H. Differences in clinical outcomes between patients with ST-elevation versus non-ST-elevation acute myocardial infarction in Korea. Korean Circ J 2009, 39:297-303.
2. Rogers W.J., Frederick P.D., Stoehr E., Canto J.G., Ornato J.P., Gibson C.M., Pollack C.V., Gore J.M., Chandra-Strobos N., Peterson E.D., French W.J. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008, 156:1026-1034.
3. Myerson M., Coady S., Taylor H., Rosamond W.D., Goff D.C. Declining severity of myocardial infarction from 1987 to 2002: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2009, 119:503-514. ARIC Investigators.
4. Steg P.G., Goldberg R.J., Gore J.M., Fox K.A., Eagle K.A., Flather M.D., Sadiq I., Kasper R., Rushton-Mellor S.K., Anderson F.A. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002, 90:358-363. GRACE Investigators.
5. Hasdai D., Behar S., Wallentin L., Danchin N., Gitt A.K., Boersma E., Fioretti P.M., Simoons M.L., Battler A. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002, 23:1190-1201.
6. Furman M.I., Dauerman H.L., Goldberg R.J., Yarzebski J., Lessard D., Gore J.M. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol 2001, 37:1571-1580.
7. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999, 354:708-715.
8. Armstrong P.W., Fu Y., Chang W.C., Topol E.J., Granger C.B., Betriu A., Van de Werf F., Lee K.L., Califf R.M. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation 1998, 98:1860-1868.
9. Singh M., Reeder G.S., Jacobsen S.J., Weston S., Killian J., Roger V.L. Scores for post-myocardial infarction risk stratification in the community. Circulation 2002, 106:2309-2314.
10. Montalescot G., Dallongeville J., Van Belle E., Rouanet S., Baulac C., Degrandsart A., Vicaut E. STEMI and NSTEMI: are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition (the OPERA registry). Eur Heart J 2007, 28:1409-1417. for the OPERA Investigators.
11. Kang D.G., Jeong M.H., Ahn Y., Chae S.C., Hur S.H., Hong T.J., Kim Y.J., Seong I.W., Chae J.K., Rhew J.Y., Chae I.H., Cho M.C., Bae J.H., Rha S.W., Kim C.J., et al. Clinical effects of hypertension on the mortality of patients with acute myocardial infarction. J KoreanMed Sci 2009, 24:800-806.
12. Lee M.G., Jeong M.H., Ahn Y., Chae S.C., Hur S.H., Hong T.J., Kim Y.J., Seong I.W., Chae J.K., Rhew J.Y., Chae I.H., Cho M.C., Bae J.H., Rha S.W., Kim C.J., et al. Comparison of clinical outcomes following acute myocardial infarctions in hypertensive patients with or without diabetes. Korean Circ J 2009, 39:243-250.
13. Li YJ, Rha SW, Chen KY, Jin Z, Minami Y, Wang L, Dang Q, Poddar KL, Ramasamy S, Park JY, Oh DJ, Jeong MH. Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease: lessons from the Korea Acute Myocardial Infarction Registry. Clin Exp Pharmacol Physiol; in press [available online January 25, 2010].
14. Lee S.H., Kim Y.J., Kim W., Park J.S., Shin D.G., Hur S.H., Kim C.J., Cho M.C., Chae S.C., Jeong M.H., Hong T.J., Kim D.I., Kim K.S. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ J 2008, 72:1410-1418. Korean Acute Myocardial Infarction Registry Investigators.
15. Gottlieb S., Harpaz D., Shotan A., Boyko V., Leor J., Cohen M., Mandelzweig L., Mazouz B., Stern S., Behar S. Sex differences in management and outcome after acute myocardial infarction in the 1990s: a prospective observational community-based study. Israeli Thrombolytic Survey Group. Circulation 2000, 102:2484-2490.
16. Vaccarino V., Parsons L., Every N.R., Barron H.V., Krumholz H.M. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999, 341:217-225.
17. Gan S.C., Beaver S.K., Houck P.M., MacLehose R.F., Lawson H.W., Chan L. Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med 2000, 343:8-15.
18. Vaccarino V., Parsons L., Peterson E.D., Rogers W.J., Kiefe C.I., Canto J. Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Arch Intern Med 2009, 169:1767-1774.
19. Marrugat J., Sala J., Masia R., Pavesi M., Sanz G., Valle V., Molina L., Seres L., Elosua R. Mortality differences between men and women following first myocardial infarction. RESCATE Investigators. Recursos Empleados en el Sindrome Coronario Agudo y Tiempo de Espera. JAMA 1998, 280:1405-1409.
20. Korea Acute Myocardial Infarction Registry (KAMIR) Investigators, Lee K.H., Jeong M.H., Ahn Y.K., Kim J.H., Chae S.C., Kim Y.J., Hur S.H., Seong I.W., Hong T.J., Choi D., Cho M.C., Kim C.J., Seung K.B., Chung W.S., et al. Gender differences of success rate of percutaneous coronary intervention and short term cardiac events in Korea Acute Myocardial Infarction Registry. Int J Cardiol 2008, 130:227-234.
21. Yoon Y.E., Rivera J.J., Kwon D.A., Chae I.H., Jeong M.H., Rha S.W., Blumenthal R.S., Nasir K., Chang H.J. National Cholesterol Education Panel III guidelines performance role in preventing myocardial infarction in a large cohort without a history of coronary artery disease: Korea Acute Myocardial Infarction Registry study. Prev Cardiol 2009, 12:109-113. other Korea Acute Myocardial Infarction Registry Investigators.
22. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
23. Diercks D.B., Roe M.T., Mulgund J., Pollack C.V., Kirk J.D., Gibler W.B., Ohman E.M., Smith S.C., Boden W.E., Peterson E.D. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J 2006, 152:140-148.
24. Buettner H.J., Mueller C., Gick M., Ferenc M., Allgeier J., Comberg T., Werner K.D., Schindler C., Neumann F.J. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 2007, 28:1694-1701.
25. Zeller M., Steg P.G., Ravisy J., Lorgis L., Laurent Y., Sicard P., Janin-Manificat L., Beer J.C., Makki H., Lagrost A.C., Rochette L., Cottin Y. Relation between body mass index, waist circumference, and death after acute myocardial infarction. Circulation 2008, 118:482-490.
26. Lee S.H., Park J.S., Kim W., Shin D.G., Kim Y.J., Kim D.S., Choi D.J., Han K.R., Kim C.J., Cho M.C., Chae S.C., Jeong M.H. Impact of body mass index and waist-to-hip ratio on clinical outcomes in patients with ST-segment elevation acute myocardial infarction (from the Korean Acute Myocardial Infarction Registry). Am J Cardiol 2008, 102:957-965. Korean Acute Myocardial Infarction Registry Investigators.
27. Kang W.Y., Jeong M.H., Ahn Y.K., Kim J.H., Chae S.C., Kim Y.J., Hur S.H., Seong I.W., Hong T.J., Choi D.H., Cho M.C., Kim C.J., Seung K.B., Chung W.S., Jang Y.S., et al. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. J Cardiol 2010, 55:84-91.
28. Spencer F.A., Goldberg R.J., Becker R.C., Gore J.M. Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol 1998, 31:1226-1233.
29. The Eurowinter Group Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. Lancet 1997, 349:1341-1346.
30. Sheth T., Nair C., Muller J., Yusuf S. Increased winter mortality from acute myocardial infarction and stroke: the effect of age. J Am Coll Cardiol 1999, 33:1916-1919.
31. Gnecchi-Ruscone T., Piccaluga E., Guzzetti S., Contini M., Montano N., Nicolis E. Morning and Monday: critical periods for the onset of acute myocardial infarction. The GISSI 2 Study experience. Eur Heart J 1994, 15:882-887.
32. Lee JH, Chae SC, Yang DH, Park HS, Cho Y, Jun JE, Park WH, Kam S, Lee WK, Kim YJ, Kim KS, Hur SH, Jeong MH, other Korea Acute Myocardial Infarction Registry Investigators. Influence of weather on daily hospital admissions for acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Int J Cardiol; in press [available online April 27, 2009].
33. Park H.E., Koo B.K., Lee W., Cho Y., Park J.S., Choi J.Y., Jeong M.H., Kim J.H., Chae S.C., Kim Y.J., Nam C.W., Lee J.H., Choi D.H., Hong T.J., Chae J.K., et al. Periodic variation and its effect on management and prognosis of Korean patients with acute myocardial infarction. Circ J 2010, 74:970-976.
34. Goldberg R.J., Currie K., White K., Brieger D., Steg P.G., Goodman S.G., Dabbous O., Fox K.A., Gore J.M. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol 2004, 93:288-293.
35. Morrow D.A., Antman E.M., Charlesworth A., Cairns R., Murphy S.A., de Lemos J.A., Giugliano R.P., McCabe C.H., Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000, 102:2031-2037.
36. Antman E.M., Cohen M., Bernink P.J., McCabe C.H., Horacek T., Papuchis G., Mautner B., Corbalan R., Radley D., Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000, 284:835-842.
37. Granger C.B., Goldberg R.J., Dabbous O., Pieper K.S., Eagle K.A., Cannon C.P., Van De Werf F., Avezum A., Goodman S.G., Flather M.D., Fox K.A. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345-2353. Global Registry of Acute Coronary Events Investigators.
38. Eagle K.A., Lim M.J., Dabbous O.H., Pieper K.S., Goldberg R.J., Van de Werf F., Goodman S.G., Granger C.B., Steg P.G., Gore J.M., Budaj A., Avezum A., Flather M.D., Fox K.A. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004, 291:2727-2733. GRACE Investigators.
39. Kim HK, Jeong MH, Ahn Y, Kim JH, Chae SC, Kim YJ, Hur SH, Seong IW, Hong TJ, Choi DH, Cho MC, Kim CJ, Seung KB, Chung WS, Jang YS, et al. A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction. Int J Cardiol; in press.[available online June 21, 2009].
40. Larsen A.I., Galbraith P., Ghali W.A., Norris C.M., Graham M.M., Knudston M.L. Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol 2005, 95:261-263. for the APPROACH Investigators.
41. Widimsky P., Stellova B., Groch L., Aschermann M., Branny M., Zelizko M., Stasek J., Formanek P. Prevalence of normal coronary angiography in the acute phase of suspected ST-elevation myocardial infarction: experience from the PRAGUE studies. Can J Cardiol 2006, 22:1147-1152. PRAGUE Study Group Investigators.
42. Bounhoure J.P. Myocardial infarction with " angiographycally normal coronary arteries" myth or reality?. Bull Acad Natl Med 2007, 191:815-824.
43. Zimmerman F.H., Cameron A., Fisher L.D., Grace N.G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 1995, 26:631-636.
44. Da Costa A., Isaaz K., Faure E., Mourot S., Cerisier A., Lamaud M. Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram; a 3-year follow-up study of 91 patients. Eur Heart J 2001, 22:1459-1465.
45. Kang WY, Jeong MH, Ahn YK, Kim JH, Chae SC, Kim YJ, Hur SH, Seong IW, Hong TJ, Choi DH, Cho MC, Kim CJ, Seung KB, Chung WS, Jang YS, et al. Are patients with angiographically near-normal coronary arteries who present as acute myocardial infarction actually safe? Int J Cardiol; in press [available online August 5, 2009].
46. Magid D.J., Wang Y., Herrin J., McNamara R.L., Bradley E.H., Curtis J.P., Pollack C.V., French W.J., Blaney M.E., Krumholz H.M. Relationship between time of day, day of week, timeliness of reperfusion, and in-hospital mortality for patients with acute ST-segment elevation myocardial infarction. JAMA 2005, 294:803-812.
47. Kostis W.J., Demissie K., Marcella S.W., Shao Y.H., Wilson A.C., Moreyra A.E. Weekend versus weekday admission and mortality from myocardial infarction. N Engl J Med 2007, 356:1099-1109.
48. Song Y.B., Hahn J.Y., Gwon H.C., Kim J.H., Lee S.H., Jeong M.H. The impact of initial treatment delay using primary angioplasty on mortality among patients with acute myocardial infarction: from the Korea acute myocardial infarction registry. J Korean Med Sci 2008, 23:357-364. KAMIR investigators.
49. Omland T., Persson A., Ng L., O'Brien R., Karlsson T., Herlitz J., Hartford M., Caidahl K. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002, 106:2913-2918.
50. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., Frampton C., Turner J., Crozier I.G., Yandle T.G. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003, 107:2786-2792.
51. Tapanainen J.M., Lindgren K.S., Makikallio T.H., Vuolteenaho O., Leppaluoto J., Huikuri H.V. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2004, 43:757-763.
52. Mega J.L., Morrow D.A., De Lemos J.A., Sabatine M.S., Murphy S.A., Rifai N., Gibson C.M., Antman E.M., Braunwald E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004, 44:335-339.
53. Kwon T.G., Bae J.H., Jeong M.H., Kim Y.J., Hur S.H., Seong I.W., Cho M.C., Seung K.B., Jang Y.S., Park S.J. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention. Int J Cardiol 2009, 133:173-178. Korea Acute Myocardial Infarction Registry Investigators.
54. Ohman E.M., Roe M.T., Smith S.C., Brindis R.G., Christenson R.H., Harrington R.A., Gibler W.B., Peterson E.D. Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative. Am Heart J 2004, 148:34-39. CRUSADE Investigators.
55. Gulati M., Patel S., Jaffe A.S., Joseph A.J., Calvin J.E. Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in The Registry of Acute Coronary Syndromes. Am J Cardiol 2004, 94:873-878.
56. Jeong H.C., Ahn Y.K., Jeong M.H., Chae S.C., Kim J.H., Seong I.W., Kim Y.J., Hur S.H., Choi D.H., Hong T.J., Yoon J.H., Rhew J.Y., Chae J.K., Kim D.I., Chae I.H., et al. Intensive pharmacologic treatment in patients with acute non ST-segment elevation myocardial infarction who did not undergo percutaneous coronary intervention. Circ J 2008, 72:1403-1409.
57. King S.B., Smith S.C., Hirshfeld J.W., Jacobs A.K., Morrison D.A., Williams D.O., 2005 Writing Committee Members, Feldman T.E., Kern M.J., O'Neill W.W., Schaff H.V., Whitlow P.L., Adams C.D., Anderson J.L., Buller C.E., et al. Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee. Circulation 2008, 117:261-295.
58. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasyamani L.K., Hochman J.S., Krumholz H.M., Lamas G.A., Mullany C.J., Pearle D.L., Sloan M.A., Smith S.C., 2004 Writing Committee Members, Anbe D.T., et al. Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008, 117:296-329.
59. Sim D.S., Jeong M.H., Ahn Y., Kim Y.J., Chae S.C., Hong T.J., Seong I.W., Chae J.K., Kim C.J., Cho M.C., Seung K.B., Park S.J. Safety and benefit of early elective percutaneous coronary intervention after successful thrombolytic therapy for acute myocardial infarction. Am J Cardiol 2009, 103:1333-1338. Korea Acute Myocardial Infarction Registry (KAMIR) Investigators.
60. Kushner F.G., Hand M., Smith S.C., King S.B., Anderson J.L., Antman E.M., Bailey S.R., Bates E.R., Blankenship J.C., Casey D.E., Green L.A., Hochman J.S., Jacobs A.K., Krumholz H.M., Morrison D.A., et al. 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009, 120:2271-2306.
61. Lee S.R., Jeong M.H., Ahn Y.K., Chae S.C., Hur S.H., Kim Y.J., Seong I.W., Chae J.K., Hong T.J., Rhew J.Y., Cho M.C., Bae J.H., Rha S.W., Kim C.J., Jang Y.S., et al. Clinical safety of drug-eluting stents in the Korea acute myocardial infarction registry. Circ J 2008, 72:392-398.
62. Kim H.K., Jeong M.H., Ahn Y.K., Kim J.H., Chae S.C., Kim Y.J., Hur S.H., Seong I.W., Hong T.J., Choi D.H., Cho M.C., Kim C.J., Seung K.B., Chung W.S., Jang Y.S., et al. Comparison of outcomes between zotarolimus- and sirolimus-eluting stents in patients with ST-segment elevation acute myocardial infarction. Am J Cardiol 2010, 105:813-818.
63. Li Y.J., Rha S.W., Chen K.Y., Poddar K.L., Jin Z., Minami Y., Wang L., Dang Q., Li G.P., Ramasamy S., Park J.Y., Choi C.U., Kim J.W., Kim E.J., Park C.G., et al. Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents. Am Heart J 2010, 159. 684-690.e1.
64. Lee S.W., Park S.W., Hong M.K., Kim Y.H., Lee B.K., Song J.M., Han K.H., Lee C.W., Kang D.H., Song J.K., Kim J.J., Park S.J. Triple versus dual anti-platelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol 2005, 46:1833-1837.
65. Chen K.Y., Rha S.W., Li Y.J., Poddar K.L., Jin Z., Minami Y., Wang L., Kim E.J., Park C.G., Seo H.S., Oh D.J., Jeong M.H., Ahn Y.K., Hong T.J., Kim Y.J., et al. Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation 2009, 119:3207-3214.